A phase II study of ACR-368 in patients with ovarian (OvCa) or endometrial carcinoma (EnCa) and prospective validation of OncoSignature patient selection (NCT05548296) Meeting Abstract
| Authors: | Lee, J. M.; MacLaughlan, S.; Matei, D.; Song, M.; Brubaker, L.; Rimmel, B.; Eskander, R. N.; Kyi, C.; Williams, H.; Duska, L.; Musa, F.; Coleman, R. L.; Slomovitz, B. M.; Gamelin, E. C.; Cuillerot, J. M.; Phadnis, M. M.; Guercio, B.; Crafton, S.; Konstantinopoulos, P. |
| Abstract Title: | A phase II study of ACR-368 in patients with ovarian (OvCa) or endometrial carcinoma (EnCa) and prospective validation of OncoSignature patient selection (NCT05548296) |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S564 |
| End Page: | S565 |
| Language: | English |
| ACCESSION: | WOS:001326612901050 |
| DOI: | 10.1016/j.annonc.2024.08.805 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 744P -- Source: Wos |
